1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Chronic Pain Management Research Program (CPMRP) Clinical Exploration Award (CEA) is sponsored by U.S. Department of Defense - Congressionally Directed Medical Research Programs (CDMRP). This award supports proof-of-principle pilot studies, clinical trials, and correlative studies that investigate hypothesis-based, innovative interventions and/or avenues of research with the potential to significantly impact chronic pain management.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Independent investigators, including faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver). Universities are eligible. Confirm the full requirements in the official notice before applying.
The current listing shows not to exceed $250,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Chronic Pain Management Research Program (CPMRP) Clinical Exploration Award (CEA) is funded by U.S. Department of Defense - Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article